Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party.

• Authors: C Koenecke, D Heim, A van Biezen, M Heuser, M Aljurf, S Kyrcz-Krzemien, L Volin, C A de Souza, T Gedde-Dahl, H Sengeloev, U Schanz, M Komarnicki, C H Arroyo, E Tholouli, E Gluckman, A Esquirol, I Yakoub-Agha, G Gürman, E Olavarria, N Kröger
• Journal: Bone marrow transplantation (Bone Marrow Transplant) Vol. 51 Issue 9 Pg. 1259-61 (09 2016) ISSN: 1476-5365 [Electronic] England
• PMID: 27111041 (Publication Type: Letter)

Topics

• Adolescent
• Adult
• Algorithms
• Child
• Decision Making
• Female
• Hematopoietic Stem Cell Transplantation (trends)
• Humans
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive (diagnosis, therapy)
• Male
• Middle Aged
• Molecular Targeted Therapy (methods)
• Risk Assessment
• Transplantation, Homologous
• Treatment Outcome
• Young Adult